Terms: = Prostate cancer AND LASP1, ENSG00000002834, 3927, Q14847, MLN50, Lasp-1
15 results:
1. Identification of miR-1-3p, miR-143-3p and miR-145-5p association with bone metastasis of Gleason 3+4 prostate cancer and involvement of lasp1 regulation.
Guo H; Zhao J; Li X; Sun F; Qin Y; Yang X; Xiong X; Yin Q; Wang X; Gao L; Jiao M; Hu J; Han B
Mol Cell Probes; 2023 Apr; 68():101901. PubMed ID: 36791996
[TBL] [Abstract] [Full Text] [Related]
2. Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/snail pathway.
Sun W; Zu S; Shao G; Wang W; Gong F
J Gene Med; 2021 Jul; 23(7):e3344. PubMed ID: 33885171
[TBL] [Abstract] [Full Text] [Related]
3. Long non-coding RNA LINC01207 promotes prostate cancer progression by downregulating microRNA-1972 and upregulating LIM and SH3 protein 1.
Wang S; Qiu J; Wang L; Wu Z; Zhang X; Li Q; Jiang F
IUBMB Life; 2020 Sep; 72(9):1960-1975. PubMed ID: 32726517
[TBL] [Abstract] [Full Text] [Related]
4. CRISP3 expression drives prostate cancer invasion and progression.
Volpert M; Furic L; Hu J; O'Connor AE; Rebello RJ; Keerthikumar S; Evans J; Merriner DJ; Pedersen J; Risbridger GP; McIntyre P; O'Bryan MK
Endocr Relat Cancer; 2020 Jul; 27(7):415-430. PubMed ID: 32357309
[TBL] [Abstract] [Full Text] [Related]
5. Proteomic-based investigations on the mode of action of the marine anticancer compound rhizochalinin.
Dyshlovoy SA; Otte K; Venz S; Hauschild J; Junker H; Makarieva TN; Balabanov S; Alsdorf WH; Madanchi R; Honecker F; Bokemeyer C; Stonik VA; von Amsberg G
Proteomics; 2017 Jun; 17(11):. PubMed ID: 28445005
[TBL] [Abstract] [Full Text] [Related]
6. Suppression of lasp-1 attenuates the carcinogenesis of prostatic cancer cell lines: Key role of the NF-κB pathway.
Sun W; Guo L; Shao G; Liu X; Guan Y; Su L; Zhao S
Oncol Rep; 2017 Jan; 37(1):341-347. PubMed ID: 27840958
[TBL] [Abstract] [Full Text] [Related]
7. Suppression of LIM and SH3 Domain Protein 1 (lasp1) Negatively Regulated by Androgen Receptor Delays Castration Resistant prostate cancer Progression.
Dejima T; Imada K; Takeuchi A; Shiota M; Leong J; Tombe T; Tam K; Fazli L; Naito S; Gleave ME; Ong CJ
Prostate; 2017 Feb; 77(3):309-320. PubMed ID: 27775154
[TBL] [Abstract] [Full Text] [Related]
8. Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (lasp1).
Endres M; Kneitz S; Orth MF; Perera RK; Zernecke A; Butt E
Oncotarget; 2016 Sep; 7(39):64244-64259. PubMed ID: 27588391
[TBL] [Abstract] [Full Text] [Related]
9. C/D-box snoRNA-derived RNA production is associated with malignant transformation and metastatic progression in prostate cancer.
Martens-Uzunova ES; Hoogstrate Y; Kalsbeek A; Pigmans B; Vredenbregt-van den Berg M; Dits N; Nielsen SJ; Baker A; Visakorpi T; Bangma C; Jenster G
Oncotarget; 2015 Jul; 6(19):17430-44. PubMed ID: 26041889
[TBL] [Abstract] [Full Text] [Related]
10. Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (lasp1) in high-risk prostate cancer thereby increasing cell proliferation and migration.
Hailer A; Grunewald TG; Orth M; Reiss C; Kneitz B; Spahn M; Butt E
Oncotarget; 2014 Jun; 5(12):4144-4153. PubMed ID: 24980827
[TBL] [Abstract] [Full Text] [Related]
11. Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of lasp1 in prostate cancer.
Nishikawa R; Goto Y; Sakamoto S; Chiyomaru T; Enokida H; Kojima S; Kinoshita T; Yamamoto N; Nakagawa M; Naya Y; Ichikawa T; Seki N
Cancer Sci; 2014 Jul; 105(7):802-11. PubMed ID: 24815849
[TBL] [Abstract] [Full Text] [Related]
12. MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines.
Viticchiè G; Lena AM; Latina A; Formosa A; Gregersen LH; Lund AH; Bernardini S; Mauriello A; Miano R; Spagnoli LG; Knight RA; Candi E; Melino G
Cell Cycle; 2011 Apr; 10(7):1121-31. PubMed ID: 21368580
[TBL] [Abstract] [Full Text] [Related]
13. Nuclear localisation of lasp-1 correlates with poor long-term survival in female breast cancer.
Frietsch JJ; Grunewald TG; Jasper S; Kammerer U; Herterich S; Kapp M; Honig A; Butt E
Br J Cancer; 2010 May; 102(11):1645-53. PubMed ID: 20461080
[TBL] [Abstract] [Full Text] [Related]
14. Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression.
Turner DP; Findlay VJ; Kirven AD; Moussa O; Watson DK
Mol Biol Cell; 2008 Sep; 19(9):3745-57. PubMed ID: 18579687
[TBL] [Abstract] [Full Text] [Related]
15. Gene expression profiles in cells transformed by overexpression of the IGF-I receptor.
Loughran G; Huigsloot M; Kiely PA; Smith LM; Floyd S; Ayllon V; O'Connor R
Oncogene; 2005 Sep; 24(40):6185-93. PubMed ID: 15940254
[TBL] [Abstract] [Full Text] [Related]
